Matches in SemOpenAlex for { <https://semopenalex.org/work/W1670276122> ?p ?o ?g. }
- W1670276122 endingPage "337" @default.
- W1670276122 startingPage "329" @default.
- W1670276122 abstract "We report our results of autologous stem cell transplantation (SCT) in patients with AML during the last 13 years. Between August 1990 and December 2003, 42 patients with acute myeloid leukemia (AML) received an autologous SCT. Patients were classified as standard risk if first complete remission (CR) was induced after one or two chemotherapy regimens and the white blood cell count at presentation was below 50,000/mL (n=12), while patients requiring more than two induction regimens to attain first CR and with CR2 ou more advanced disease and/or had a higher white blood cell count at presentation were defined as high risk (n=30). Twenty one patients were transplanted in first CR. The median patient age was 24 years (range, 2-56 years), and the median time interval from diagnosis to autologous SCT was 9 months (range 3-87 months). The conditioning regimen for SCT consisted of busulfan (BU) 16 mg/kg and melfalan (MEL) 180 mg/m2 (BUMEL) in 17 (40%) patients and busulfan 16 mg/kg and VP-16 60 mg/kg (BUVP16) in 22 (52%) patients. Three patients received a different conditioning regimen with BCNU 300 mg/m2, VP16 2 g/m2 and melphalan 160 mg/m2 (BEM). Twenty five (60%) patients received bone marrow (BM), 11 (26%) patients received peripheral blood stem cells (PBSC) and 6 patients (14%) received BM plus PBSC. With a median follow-up of 7 years, the 13 year overall survival (OS) and diseasefree survival (DFS) of all patients is 52% and 40%, respectively. In univariate analysis, males had a significantly superior DFS than females (55% vs 22%, p=0.003), and patients younger than 15 years of age had significantly superior OS and DFS than older patients (50% vs 35%, p=0.05; and 50% vs 28%, p=0.03, respectively). Patients with FAB M3 subtype also had a superior OS than the other FAB subtypes (100% vs 44%, p=0.05). There was a strong statistical correlation between risk group and survival. In fact, the patients with standard risk had a superior OS and DFS than those with high risk disease (67% vs 23%, p=0.0004; and 50% vs 27%, p=0.01, respectively). When patients with FAB M3 disease were excluded from the analysis, the group with standard risk continue to have a superior OS and DFS (67% vs 13%, p=0.008; and 50% vs 14%, p=0.02, respectively). We conclude that autologous SCT is an effective treatment in AML with the possibility of long survivorship, particularly in patients with standard risk disease." @default.
- W1670276122 created "2016-06-24" @default.
- W1670276122 creator A5021249910 @default.
- W1670276122 creator A5055224761 @default.
- W1670276122 creator A5063731373 @default.
- W1670276122 creator A5073689276 @default.
- W1670276122 creator A5068584699 @default.
- W1670276122 date "2005-09-01" @default.
- W1670276122 modified "2023-09-27" @default.
- W1670276122 title "Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience." @default.
- W1670276122 cites W1533557093 @default.
- W1670276122 cites W2041111639 @default.
- W1670276122 cites W2131311832 @default.
- W1670276122 cites W2137403747 @default.
- W1670276122 cites W2140439802 @default.
- W1670276122 cites W2176980523 @default.
- W1670276122 cites W2314275158 @default.
- W1670276122 cites W2322358118 @default.
- W1670276122 cites W2322720394 @default.
- W1670276122 cites W2402046908 @default.
- W1670276122 cites W2417189647 @default.
- W1670276122 cites W2417246488 @default.
- W1670276122 cites W296196436 @default.
- W1670276122 cites W6130862 @default.
- W1670276122 cites W97888389 @default.
- W1670276122 doi "https://doi.org/10.20344/amp.1046" @default.
- W1670276122 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16611537" @default.
- W1670276122 hasPublicationYear "2005" @default.
- W1670276122 type Work @default.
- W1670276122 sameAs 1670276122 @default.
- W1670276122 citedByCount "2" @default.
- W1670276122 countsByYear W16702761222015 @default.
- W1670276122 crossrefType "journal-article" @default.
- W1670276122 hasAuthorship W1670276122A5021249910 @default.
- W1670276122 hasAuthorship W1670276122A5055224761 @default.
- W1670276122 hasAuthorship W1670276122A5063731373 @default.
- W1670276122 hasAuthorship W1670276122A5068584699 @default.
- W1670276122 hasAuthorship W1670276122A5073689276 @default.
- W1670276122 hasConcept C126322002 @default.
- W1670276122 hasConcept C141071460 @default.
- W1670276122 hasConcept C2776611710 @default.
- W1670276122 hasConcept C2776694085 @default.
- W1670276122 hasConcept C2777408962 @default.
- W1670276122 hasConcept C2778488018 @default.
- W1670276122 hasConcept C2778684742 @default.
- W1670276122 hasConcept C2778729363 @default.
- W1670276122 hasConcept C2780007613 @default.
- W1670276122 hasConcept C2780611847 @default.
- W1670276122 hasConcept C2781413609 @default.
- W1670276122 hasConcept C28328180 @default.
- W1670276122 hasConcept C2911091166 @default.
- W1670276122 hasConcept C54355233 @default.
- W1670276122 hasConcept C71924100 @default.
- W1670276122 hasConcept C86803240 @default.
- W1670276122 hasConcept C90924648 @default.
- W1670276122 hasConceptScore W1670276122C126322002 @default.
- W1670276122 hasConceptScore W1670276122C141071460 @default.
- W1670276122 hasConceptScore W1670276122C2776611710 @default.
- W1670276122 hasConceptScore W1670276122C2776694085 @default.
- W1670276122 hasConceptScore W1670276122C2777408962 @default.
- W1670276122 hasConceptScore W1670276122C2778488018 @default.
- W1670276122 hasConceptScore W1670276122C2778684742 @default.
- W1670276122 hasConceptScore W1670276122C2778729363 @default.
- W1670276122 hasConceptScore W1670276122C2780007613 @default.
- W1670276122 hasConceptScore W1670276122C2780611847 @default.
- W1670276122 hasConceptScore W1670276122C2781413609 @default.
- W1670276122 hasConceptScore W1670276122C28328180 @default.
- W1670276122 hasConceptScore W1670276122C2911091166 @default.
- W1670276122 hasConceptScore W1670276122C54355233 @default.
- W1670276122 hasConceptScore W1670276122C71924100 @default.
- W1670276122 hasConceptScore W1670276122C86803240 @default.
- W1670276122 hasConceptScore W1670276122C90924648 @default.
- W1670276122 hasIssue "5" @default.
- W1670276122 hasLocation W16702761221 @default.
- W1670276122 hasLocation W16702761222 @default.
- W1670276122 hasOpenAccess W1670276122 @default.
- W1670276122 hasPrimaryLocation W16702761221 @default.
- W1670276122 hasRelatedWork W154474755 @default.
- W1670276122 hasRelatedWork W2407946965 @default.
- W1670276122 hasRelatedWork W2492440520 @default.
- W1670276122 hasRelatedWork W2534137309 @default.
- W1670276122 hasRelatedWork W2548078768 @default.
- W1670276122 hasRelatedWork W2548097557 @default.
- W1670276122 hasRelatedWork W2556675457 @default.
- W1670276122 hasRelatedWork W2557214410 @default.
- W1670276122 hasRelatedWork W2558322760 @default.
- W1670276122 hasRelatedWork W2566849950 @default.
- W1670276122 hasRelatedWork W2567594949 @default.
- W1670276122 hasRelatedWork W2575554787 @default.
- W1670276122 hasRelatedWork W2587351747 @default.
- W1670276122 hasRelatedWork W2588142421 @default.
- W1670276122 hasRelatedWork W2588545497 @default.
- W1670276122 hasRelatedWork W2592606920 @default.
- W1670276122 hasRelatedWork W2594121809 @default.
- W1670276122 hasRelatedWork W2605415016 @default.
- W1670276122 hasRelatedWork W2885807473 @default.
- W1670276122 hasRelatedWork W2979982544 @default.
- W1670276122 hasVolume "18" @default.